Syngular Technology

About the solution

Syngular Technology is a Hong Kong based healthtech company developing an artificial intelligence and augmented reality powered platform that provides real time surgical guidance inside the operating room. Many hospitals still rely on 2D imaging, memory and experience to guide high risk procedures, which results in longer operation times, higher complication rates and higher costs. Syngular combines augmented reality overlays, AI automated anatomical segmentation and digital twin generation to give surgeons spatially aware guidance throughout a procedure. This improves accuracy, reduces preparation time and creates a more intuitive workflow for complex interventions.

The solution addresses two core challenges in surgical care. First, it brings advanced, real time navigational support into operating rooms that lack access to expensive surgical robots and navigation systems. Second, it improves safety and efficiency by enabling surgeons to visualise patient anatomy in three dimensions and interact with digital models throughout the procedure. Syngular’s technology has already been used in more than 80 patient cases, including a pilot with the Hong Kong Hospital Authority, and is gaining traction through medical education partnerships and B2B adoption across Hong Kong.

EQT Foundation’s Investment

EQT Foundation has invested 100,000 euros in Syngular Technology following the company’s win at the EQT Impact Challenge in Hong Kong. The investment was made through a SAFE and will support the team as they scale their product across hospitals in Hong Kong and build capacity to meet growing clinical demand. Syngular will also gain access to EQT’s global network of healthcare partners and technology experts. By enabling more precise and efficient surgery through the fusion of AI and extended reality, this investment supports a solution with strong potential to improve patient outcomes and strengthen healthcare systems, particularly in settings where resources are limited.